About

About Symani Surgical System

Symani uses two articulated robotic arms carrying NanoWrist microinstruments that reproduce wrist movement at the scale required for vessels and anatomical structures measured in millimetres. The surgeon operates from an open console, with motion scaling and tremor filtering translating hand movement into controlled instrument motion.

The system supports suturing, ligation, anastomosis and dissection in open microsurgical procedures, including lymphatic, reconstructive and peripheral-nerve work. It preserves direct access to the patient while reducing the physical constraints of manual microinstrument handling. MMI supplies the robot, disposable instruments, training and clinical support across authorised markets.

Operations

Operating Milestone
3500 procedures - 2026-10-08 - MMI disclosed 3,500 complex microsurgical procedures performed worldwide using Symani by October 8, 2026.
Source

Deployments

Operating Use
approximately 50 installed systems - 2026-10-08 - MMI reported approximately 50 Symani Surgical Systems installed worldwide as of its October 8 financing announcement.
Source

Timeline

MMI raises $125 million Series D for Symani commercial expansion
2026-10-08 - Funding - Approximately 50 Symani systems are installed, with 3,500 complex microsurgical procedures performed worldwide. Proceeds support expansion in the United States and other markets, clinical evidence including REMIND, and energy-instrument and digital-surgery development.
Source
MMI receives FDA approval to expand REMIND microsurgery study
2026-07-30 - Regulatory - The supplement followed FDA review of 30-day safety data from the first patient cohort. REMIND evaluates Symani-enabled microsurgical techniques intended to re-establish deep-cervical lymphatic drainage in patients with Alzheimer's disease and confirmed lymphatic abnormalities. The study remains an early-feasibility investigation; Symani is not FDA-cleared for lymphatic reconstruction for brain disease.
Source